BSE
TORNTPHARM

TORRENT PHARMACEUTICALS LTD.

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

TORRENT PHARMACEUTICALS LTD. Stock Price

Vitals

Today's Low:
₹1847.5
Today's High:
₹1885.75
Open Price:
₹1865.25
52W Low:
₹1224.2305
52W High:
₹1734.0967
Prev. Close:
₹1867.8
Volume:
7652

Company Statistics

Market Cap.:
₹533.36 billion
Book Value:
179.997
Revenue TTM:
₹92.58 billion
Operating Margin TTM:
21.59%
Gross Profit TTM:
₹60.66 billion
Profit Margin:
8.98%
Return on Assets TTM:
8.54%
Return on Equity TTM:
12.95%

Company Profile

TORRENT PHARMACEUTICALS LTD. had its IPO on under the ticker symbol TORNTPHARM.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. TORRENT PHARMACEUTICALS LTD. has a staff strength of 12,703 employees.

Stock update

Shares of TORRENT PHARMACEUTICALS LTD. opened at ₹1865.25 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹1847.5 - ₹1885.75, and closed at ₹1857.35.

This is a -0.56% slip from the previous day's closing price.

A total volume of 7,652 shares were traded at the close of the day’s session.

In the last one week, shares of TORRENT PHARMACEUTICALS LTD. have increased by +1.58%.

TORRENT PHARMACEUTICALS LTD.'s Key Ratios

TORRENT PHARMACEUTICALS LTD. has a market cap of ₹533.36 billion, indicating a price to book ratio of 9.0132 and a price to sales ratio of 6.1208.

In the last 12-months TORRENT PHARMACEUTICALS LTD.’s revenue was ₹92.58 billion with a gross profit of ₹60.66 billion and an EBITDA of ₹26.16 billion. The EBITDA ratio measures TORRENT PHARMACEUTICALS LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, TORRENT PHARMACEUTICALS LTD.’s operating margin was 21.59% while its return on assets stood at 8.54% with a return of equity of 12.95%.

In Q4, TORRENT PHARMACEUTICALS LTD.’s quarterly earnings growth was a positive 13.4% while revenue growth was a positive 18.2%.

TORRENT PHARMACEUTICALS LTD.’s PE and PEG Ratio

Forward PE
35.461
Trailing PE
64.1392
PEG

Its diluted EPS in the last 12-months stands at ₹24.57 per share while it has a forward price to earnings multiple of 35.461 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into TORRENT PHARMACEUTICALS LTD.’s profitability.

TORRENT PHARMACEUTICALS LTD. stock is trading at a EV to sales ratio of 6.6387 and a EV to EBITDA ratio of 27.017. Its price to sales ratio in the trailing 12-months stood at 6.1208.

TORRENT PHARMACEUTICALS LTD. stock pays annual dividends of ₹18 per share, indicating a yield of 1.16% and a payout ratio of 73.25%.

Balance sheet and cash flow metrics

Total Assets
₹0
Total Liabilities
₹0
Operating Cash Flow
₹0
Capital Expenditure
₹0
Dividend Payout Ratio
73.25%

TORRENT PHARMACEUTICALS LTD. ended 2024 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.

TORRENT PHARMACEUTICALS LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

TORRENT PHARMACEUTICALS LTD.’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.

In 2024, TORRENT PHARMACEUTICALS LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, TORRENT PHARMACEUTICALS LTD. paid ₹0.73 in dividends in 2024.

Other key metrics

Current Trading Price
₹1857.35
52-Week High
₹1734.0967
52-Week Low
₹1224.2305
Analyst Target Price

TORRENT PHARMACEUTICALS LTD. stock is currently trading at ₹1857.35 per share. It touched a 52-week high of ₹1734.0967 and a 52-week low of ₹1734.0967. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹1945.63 and 200-day moving average was ₹1692.11 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 7135.3% of the company’s stock are held by insiders while 1473.5% are held by institutions.

Frequently Asked Questions About TORRENT PHARMACEUTICALS LTD.

The stock symbol (also called stock or share ticker) of TORRENT PHARMACEUTICALS LTD. is TORNTPHARM

The IPO of TORRENT PHARMACEUTICALS LTD. took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
₹72.68
-3.4
-4.47%
₹19.49
0.18
+0.93%
Adani Power Limited (ADANIPOWER)
₹386.3
-12.1
-3.04%
₹0.83
-0.01
-1.55%
₹20.57
-0.05
-0.24%
₹3678.55
-198.4
-5.12%
₹0.63
0.02
+3.82%
₹0.03
0
+10%
₹34.44
-0.7
-1.99%
₹140.8
-14.65
-9.42%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Address

Torrent House, Ahmedabad, India, 380009